Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
China flag China · Delayed Price · Currency is CNY
45.21
+0.28 (0.62%)
Jul 29, 2026, 3:00 PM CST

SHA:688799 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
223.94238.28164.32211.32182.8160.76
Depreciation & Amortization
71.0571.0569.3161.0248.7934.22
Other Amortization
5.785.782.811.30.530.06
Loss (Gain) From Sale of Assets
00--0-0.18
Asset Writedown & Restructuring Costs
0.030.030.030.480.890.21
Loss (Gain) From Sale of Investments
-84.46-84.4624.16-3.58-7.98-1.71
Provision & Write-off of Bad Debts
1.691.690.311.472.231.31
Other Operating Activities
45.35-0.53-30.16-19.19-5.343.08
Change in Accounts Receivable
-56.44-56.44-118.65-51.3311.32-31.56
Change in Inventory
11.0711.07-55.23-31-43.25-115.58
Change in Accounts Payable
60.4160.41106.3950.84-34.7766.49
Change in Other Net Operating Assets
51.9651.96----
Operating Cash Flow
331.74300.2142.23214.44155.65114.72
Operating Cash Flow Growth
164.75%111.07%-33.68%37.78%35.67%9.62%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-609.76-520.32-233.87-105.76-131.85-92.1
Sale of Property, Plant & Equipment
0.070.070.020.050.120.13
Cash Acquisitions
----0.07-
Divestitures
5.975.97----
Investment in Securities
-149.23-106.47-125.21134.47-111.7-429.6
Other Investing Activities
9.811.570.2410.3712.744.26
Investing Cash Flow
-743.15-609.17-358.8239.12-230.62-517.3

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-384100.6117.11--
Total Debt Issued
537.86384100.6117.11--
Net Debt Issued (Repaid)
537.86384100.6117.11--
Issuance of Common Stock
14.9714.97---674.02
Common Dividends Paid
-66.11-62.96-86.35-84.44-65.66-
Other Financing Activities
-9.97--9.87-10.71-18.36
Financing Cash Flow
476.75336.0114.26-57.47-76.37655.65

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.59-0.990.420.010.53-0.03
Net Cash Flow
63.7526.04-201.91196.11-150.82253.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-278.02-220.12-91.65108.6823.822.63
Free Cash Flow Growth
---356.70%5.18%-55.56%
Free Cash Flow Margin
-18.63%-14.63%-6.49%7.58%1.84%1.97%
Free Cash Flow Per Share
-2.06-1.64-0.700.830.180.20
Levered Free Cash Flow
-167.53-437.09-166.469.89-40.72-33.38
Unlevered Free Cash Flow
-166.4-436.69-166.3969.89-40.72-33.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
154.8142.82198.54192.83152.18132.83
Change in Working Capital
68.3668.36-88.55-38.36-66.28-83.39